GO:0000278 | mitotic cell cycle | 1.72e-06 | 1.68e-02 | 4.281 | 5 | 35 | 314 |
GO:0005654 | nucleoplasm | 1.23e-05 | 1.20e-01 | 3.064 | 6 | 55 | 876 |
GO:0006206 | pyrimidine nucleobase metabolic process | 7.94e-05 | 7.75e-01 | 7.166 | 2 | 2 | 17 |
GO:0042995 | cell projection | 4.74e-04 | 1.00e+00 | 5.896 | 2 | 2 | 41 |
GO:0043234 | protein complex | 5.07e-04 | 1.00e+00 | 4.124 | 3 | 8 | 210 |
GO:0031100 | organ regeneration | 5.46e-04 | 1.00e+00 | 5.794 | 2 | 2 | 44 |
GO:0006334 | nucleosome assembly | 7.34e-04 | 1.00e+00 | 5.581 | 2 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.34e-04 | 1.00e+00 | 5.581 | 2 | 5 | 51 |
GO:0005829 | cytosol | 7.44e-04 | 1.00e+00 | 2.035 | 6 | 58 | 1787 |
GO:0004151 | dihydroorotase activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 1.50e-03 | 1.00e+00 | 5.064 | 2 | 7 | 73 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0006543 | glutamine catabolic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0006260 | DNA replication | 2.47e-03 | 1.00e+00 | 4.699 | 2 | 11 | 94 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.63e-03 | 1.00e+00 | 4.653 | 2 | 5 | 97 |
GO:0051414 | response to cortisol | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0043248 | proteasome assembly | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0001940 | male pronucleus | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0014075 | response to amine | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0001939 | female pronucleus | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0070062 | extracellular vesicular exosome | 4.77e-03 | 1.00e+00 | 1.895 | 5 | 43 | 1641 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 7 |
GO:0033762 | response to glucagon | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 7 |
GO:0000812 | Swr1 complex | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 7 |
GO:0031122 | cytoplasmic microtubule organization | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 2 | 8 |
GO:0051290 | protein heterotetramerization | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0035067 | negative regulation of histone acetylation | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0031011 | Ino80 complex | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 2 | 8 |
GO:0021846 | cell proliferation in forebrain | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0007067 | mitotic nuclear division | 7.43e-03 | 1.00e+00 | 3.887 | 2 | 8 | 165 |
GO:0010467 | gene expression | 7.44e-03 | 1.00e+00 | 2.775 | 3 | 31 | 535 |
GO:0016071 | mRNA metabolic process | 7.87e-03 | 1.00e+00 | 3.844 | 2 | 21 | 170 |
GO:0043025 | neuronal cell body | 7.96e-03 | 1.00e+00 | 3.836 | 2 | 3 | 171 |
GO:0006541 | glutamine metabolic process | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0004864 | protein phosphatase inhibitor activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0043968 | histone H2A acetylation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 10 |
GO:0005838 | proteasome regulatory particle | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 10 |
GO:0007020 | microtubule nucleation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0008601 | protein phosphatase type 2A regulator activity | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0016070 | RNA metabolic process | 9.56e-03 | 1.00e+00 | 3.699 | 2 | 21 | 188 |
GO:0035267 | NuA4 histone acetyltransferase complex | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 3 | 12 |
GO:0048863 | stem cell differentiation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 12 |
GO:0015949 | nucleobase-containing small molecule interconversion | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 12 |
GO:0006337 | nucleosome disassembly | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 13 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 13 |
GO:0016020 | membrane | 1.08e-02 | 1.00e+00 | 2.016 | 4 | 38 | 1207 |
GO:0022624 | proteasome accessory complex | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 7 | 14 |
GO:0005515 | protein binding | 1.21e-02 | 1.00e+00 | 1.051 | 7 | 76 | 4124 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0006913 | nucleocytoplasmic transport | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0017144 | drug metabolic process | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 22 |
GO:0005634 | nucleus | 1.93e-02 | 1.00e+00 | 1.174 | 6 | 67 | 3246 |
GO:0003730 | mRNA 3'-UTR binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 25 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 2 | 29 |
GO:0010212 | response to ionizing radiation | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 30 |
GO:0043195 | terminal bouton | 2.51e-02 | 1.00e+00 | 5.299 | 1 | 1 | 31 |
GO:0044281 | small molecule metabolic process | 2.59e-02 | 1.00e+00 | 2.117 | 3 | 32 | 844 |
GO:0007595 | lactation | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 2 | 32 |
GO:0060041 | retina development in camera-type eye | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 2 | 34 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 2.99e-02 | 1.00e+00 | 5.044 | 1 | 2 | 37 |
GO:0005524 | ATP binding | 3.00e-02 | 1.00e+00 | 2.037 | 3 | 23 | 892 |
GO:0035690 | cellular response to drug | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 5 | 38 |
GO:0042802 | identical protein binding | 3.17e-02 | 1.00e+00 | 2.786 | 2 | 7 | 354 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.31e-02 | 1.00e+00 | 4.896 | 1 | 16 | 41 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.31e-02 | 1.00e+00 | 4.896 | 1 | 2 | 41 |
GO:0043086 | negative regulation of catalytic activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 45 |
GO:0050790 | regulation of catalytic activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 45 |
GO:0005737 | cytoplasm | 3.74e-02 | 1.00e+00 | 1.213 | 5 | 50 | 2633 |
GO:0000502 | proteasome complex | 3.79e-02 | 1.00e+00 | 4.699 | 1 | 17 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 6 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 17 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 17 | 53 |
GO:0042393 | histone binding | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 54 |
GO:0005681 | spliceosomal complex | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 2 | 55 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.50e-02 | 1.00e+00 | 4.446 | 1 | 17 | 56 |
GO:0008584 | male gonad development | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 2 | 57 |
GO:0032355 | response to estradiol | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 1 | 57 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 16 | 57 |
GO:0007265 | Ras protein signal transduction | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 3 | 59 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 17 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 5 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 16 | 61 |
GO:0007565 | female pregnancy | 5.13e-02 | 1.00e+00 | 4.253 | 1 | 2 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 17 | 65 |
GO:0005200 | structural constituent of cytoskeleton | 5.44e-02 | 1.00e+00 | 4.166 | 1 | 2 | 68 |
GO:0006325 | chromatin organization | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 16 | 70 |
GO:0001889 | liver development | 5.67e-02 | 1.00e+00 | 4.104 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 5.91e-02 | 1.00e+00 | 4.044 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 6.14e-02 | 1.00e+00 | 3.987 | 1 | 1 | 77 |
GO:0030529 | ribonucleoprotein complex | 6.53e-02 | 1.00e+00 | 3.896 | 1 | 4 | 82 |
GO:0005635 | nuclear envelope | 6.60e-02 | 1.00e+00 | 3.878 | 1 | 4 | 83 |
GO:0043524 | negative regulation of neuron apoptotic process | 6.76e-02 | 1.00e+00 | 3.844 | 1 | 1 | 85 |
GO:0000209 | protein polyubiquitination | 7.30e-02 | 1.00e+00 | 3.730 | 1 | 16 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.30e-02 | 1.00e+00 | 3.730 | 1 | 2 | 92 |
GO:0016887 | ATPase activity | 7.91e-02 | 1.00e+00 | 3.610 | 1 | 6 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.29e-02 | 1.00e+00 | 3.539 | 1 | 18 | 105 |
GO:0007507 | heart development | 8.36e-02 | 1.00e+00 | 3.525 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 8.36e-02 | 1.00e+00 | 3.525 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 8.59e-02 | 1.00e+00 | 3.485 | 1 | 3 | 109 |
GO:0042981 | regulation of apoptotic process | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 18 | 112 |
GO:0003924 | GTPase activity | 9.35e-02 | 1.00e+00 | 3.359 | 1 | 3 | 119 |
GO:0004672 | protein kinase activity | 9.80e-02 | 1.00e+00 | 3.288 | 1 | 2 | 125 |
GO:0000082 | G1/S transition of mitotic cell cycle | 9.80e-02 | 1.00e+00 | 3.288 | 1 | 24 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 1.00e-01 | 1.00e+00 | 3.253 | 1 | 8 | 128 |
GO:0006184 | GTP catabolic process | 1.02e-01 | 1.00e+00 | 3.231 | 1 | 3 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.11e-01 | 1.00e+00 | 3.104 | 1 | 2 | 142 |
GO:0008380 | RNA splicing | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 7 | 165 |
GO:0007283 | spermatogenesis | 1.30e-01 | 1.00e+00 | 2.861 | 1 | 2 | 168 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 6 | 176 |
GO:0005525 | GTP binding | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 5 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 1 | 203 |
GO:0006281 | DNA repair | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 19 | 203 |
GO:0019899 | enzyme binding | 1.60e-01 | 1.00e+00 | 2.539 | 1 | 4 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 1.65e-01 | 1.00e+00 | 2.485 | 1 | 7 | 218 |
GO:0005813 | centrosome | 1.65e-01 | 1.00e+00 | 2.492 | 1 | 8 | 217 |
GO:0019901 | protein kinase binding | 1.75e-01 | 1.00e+00 | 2.395 | 1 | 11 | 232 |
GO:0003723 | RNA binding | 1.85e-01 | 1.00e+00 | 2.305 | 1 | 11 | 247 |
GO:0055114 | oxidation-reduction process | 2.26e-01 | 1.00e+00 | 1.987 | 1 | 3 | 308 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.32e-01 | 1.00e+00 | 1.945 | 1 | 7 | 317 |
GO:0043066 | negative regulation of apoptotic process | 2.35e-01 | 1.00e+00 | 1.922 | 1 | 20 | 322 |
GO:0048471 | perinuclear region of cytoplasm | 2.49e-01 | 1.00e+00 | 1.827 | 1 | 5 | 344 |
GO:0005730 | nucleolus | 2.63e-01 | 1.00e+00 | 1.004 | 2 | 41 | 1217 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.70e-01 | 1.00e+00 | 1.695 | 1 | 10 | 377 |
GO:0005783 | endoplasmic reticulum | 2.73e-01 | 1.00e+00 | 1.680 | 1 | 3 | 381 |
GO:0006915 | apoptotic process | 2.91e-01 | 1.00e+00 | 1.570 | 1 | 21 | 411 |
GO:0005794 | Golgi apparatus | 2.94e-01 | 1.00e+00 | 1.556 | 1 | 5 | 415 |
GO:0016032 | viral process | 3.01e-01 | 1.00e+00 | 1.512 | 1 | 32 | 428 |
GO:0008270 | zinc ion binding | 4.62e-01 | 1.00e+00 | 0.748 | 1 | 7 | 727 |
GO:0044822 | poly(A) RNA binding | 4.95e-01 | 1.00e+00 | 0.611 | 1 | 25 | 799 |
GO:0003677 | DNA binding | 5.58e-01 | 1.00e+00 | 0.366 | 1 | 18 | 947 |
GO:0006351 | transcription, DNA-templated | 6.07e-01 | 1.00e+00 | 0.182 | 1 | 9 | 1076 |